BioSpace News Archive

Zymeworks Inc. today announced that the Company will present at the upcoming Ladenburg Thalmann Healthcare Conference on July 14, 2021 at 4:00 p.m. ET.

Today, Akston Biosciences Corporation , a developer of new classes of biologic therapeutics announced positive results from a 60-subject, open-label, Phase I trial of AKS-452, its protein subunit, room temperature stable, COVID-19 vaccine candidate.

NeurOptics, the worldwide leader in the science of pupillometry, announced the U.S. launch of its NPi®-300, a next-generation automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, guiding treatment and informing prognosis for clinicians and their patients.

Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion Rob Brainin Named Executive Vice President and Chief Business Officer; Bill Zondler Appointed Senior Vice President and Chief Information Officer

Vect-Horus and RadioMedix are pleased to announce the FDA clearance of exploratory Investigational New Drug (eIND) application to evaluate 68 Ga-RMX-VH for the detection and mapping of Low Density Lipoprotein Receptor (LDLR) overexpressed in Glioblastoma Multiforme (GBM).

BioPhotas, Inc., the market leader in therapeutic LED Light Therapy devices announced today a major product line extension to the Company’s award-winning Celluma SERIES of Light Therapy Devices

The Fetal Institute, Miami, which specializes in the assessment, counseling, and management of patients with high-risk pregnancies, is conducting a clinical trial of fetoscopic repair in open spina bifida, a minimally invasive procedure developed by doctors at the Institute and the USFetus in collaboration with colleagues in Brazil.

Sunshine Biopharma Inc. today announced that it has succeeded in inhibiting the activity of Nrf2 using mRNA vaccine technology. Nrf2 is a transcription factor responsible for activation of oxidative stress genes as well as the cancer multidrug resistance genes, MDR1 (p-Glycoprotein), MRP1 and BCRP.

The Terasaki Institute for Biomedical Innovation announces the establishment of their Scientific Advisory Board.

Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company founded on the belief that patients should always come first, recognizes that mental health is important for everyone—including professional athletes.